Marjolein Crabbe
Beerse, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens.
Journal: Nature communications
Published: November 04, 2024
Serum and mucosal antibody-mediated protection and identification of asymptomatic respiratory syncytial virus infection in community-dwelling older adults in Europe.
Journal: Frontiers in immunology
Published: June 13, 2024
The influence of resolution on the predictive power of spatial heterogeneity measures as biomarkers of liver fibrosis.
Journal: Computers in biology and medicine
Published: October 09, 2023
Single-cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants.
Journal: Clinical and translational medicine
Published: July 10, 2023
A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults.
Journal: Antiviral therapy
Published: May 18, 2023
Measures of spatial heterogeneity in the liver tissue micro-environment as predictive factors for fibrosis score.
Journal: Computers in biology and medicine
Published: April 28, 2023
Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates.
Journal: Nature
Published: June 29, 2022
Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction.
Journal: Nature
Published: October 21, 2021
A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction.
Journal: Nature
Published: June 30, 2020
Last Updated: 09/26/2026